Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$24.4 - $41.3 $5,612 - $9,499
-230 Reduced 73.48%
83 $3,000
Q3 2022

Oct 14, 2022

SELL
$28.48 - $52.59 $2,990 - $5,521
-105 Reduced 25.12%
313 $9,000
Q2 2022

Jul 25, 2022

BUY
$36.95 - $82.41 $665 - $1,483
18 Added 4.5%
418 $19,000
Q1 2022

May 05, 2022

BUY
$55.7 - $145.79 $5,514 - $14,433
99 Added 32.89%
400 $30,000
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $40,650 - $54,959
301 New
301 $45,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.